Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in

  News Archive

$6 Million Awarded to Develop Alternative HIV/AIDS Vaccine
Thursday, September 24, 2015
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded up to nearly $6 million from the Bill & Melinda Gates Foundation to develop a revolutionary HIV/AIDS alternative vaccine that has demonstrated great potential in animal models.

Old Drug Performs New Tricks
Wednesday, September 23, 2015
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.

Lipid Therapeutics Licenses Rights to UC Therapy to Nestlé Health Science
Monday, September 21, 2015
Lipid Therapeutics has announced that it has entered into a licensing agreement with Nestlé Health Science for exclusive rights to Lipid Therapeutics’ LT-02 compound a novel barrier function therapy for patients with mild-to-moderate ulcerative colitis.

Diabetes Drugs May Actually Release Sugar Into the Blood
Monday, September 21, 2015
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.

Nanoparticles Can Make Medicines More Effective
Friday, September 18, 2015
Nanoparticles wrapped inside human platelet membranes serve as new vehicles for targeted drug delivery.

A Better Class of Cancer Drugs
Friday, September 18, 2015
An SDSU chemist has developed a technique to identify potential cancer drugs that are less likely to produce side effects.

Preventing Crystallization to Improve Drug Efficiency
Thursday, September 17, 2015
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.

Amgen To Acquire Privately-Held Dezima Pharma
Thursday, September 17, 2015
This move strengthens Amgen's cardiovascular portfolio with late-stage, oral CETP inhibitor.

Celgene, Nurix Announce Collaboration
Thursday, September 17, 2015
The two companies are set to work on the discovery, development and commercialization of novel small molecule therapeutics in oncology, inflammation and immunology, including the rapidly evolving field of immunooncology.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 4197

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos